pimonidazole has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, LMK; Galappathi, K; Gaustad, JV; Hauge, A; Rofstad, EK; Simonsen, TG; Wegner, CS | 1 |
| Dhani, NC; Gallinger, S; Hedley, DW; Hill, RP; Pintilie, M; Schwock, J; Serra, S; Xu, J | 1 |
1 trial(s) available for pimonidazole and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole.
Topics: Adult; Analysis of Variance; Carcinoma, Pancreatic Ductal; Cell Hypoxia; Feasibility Studies; Female; Humans; Immunohistochemistry; Indicators and Reagents; Injections, Intravenous; Male; Nitroimidazoles; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Premedication; Selection Bias | 2015 |
1 other study(ies) available for pimonidazole and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Topics: Animals; Carcinoma, Pancreatic Ductal; Contrast Media; Extracellular Fluid; Female; Heterocyclic Compounds; Heterografts; Humans; Hypoxia; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neoplasm Transplantation; Nitroimidazoles; Organometallic Compounds; Pancreatic Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Pressure; Tumor Microenvironment | 2017 |